https://biotechmorning.com/news/axsome-sunosi-patent-settlement-2040-generic-block Biotech Morning en 2026-06-05T14:23:09.609Z Axsome Just Built a 14-Year Moat Around Its Sleep Drug https://biotechmorning.com/news/adc-drug-class-zynlonta-safety-deaths-reality-check Biotech Morning en 2026-06-05T14:22:15.714Z The Hottest Drug Class in Oncology Just Got a Reality Check https://biotechmorning.com/news/supreme-court-skinny-label-ruling-hikma-generic-win Biotech Morning en 2026-06-05T14:21:22.320Z The Supreme Court Just Made It Way Harder to Sue Generic Drugmakers https://biotechmorning.com/news/ra-capital-china-clinical-expertise-in-a-box Biotech Morning en 2026-06-05T14:20:29.449Z RA Capital's Playbook for Smuggling China's Best Biotech Tricks Into the US https://biotechmorning.com/news/rallybio-avenzo-reverse-merger-oncology Biotech Morning en 2026-06-05T14:19:36.500Z Rallybio Just Gave Away 97% of Itself (and Investors Are Thrilled) https://biotechmorning.com/news/autobahn-thyroid-bipolar-depression-phase-2 Biotech Morning en 2026-06-05T14:18:41.431Z Thyroid Hormones for Depression? This Tiny Trial Just Made Big Pharma Pay Attention. https://biotechmorning.com/news/parabilis-medicines-ipo-filing-2026 Biotech Morning en 2026-06-05T14:17:46.324Z Biotech's Biggest Bet of the Year Just Filed to Go Public https://biotechmorning.com/news/binsa-bill-biotech-investment-china-restrictions Biotech Morning en 2026-06-05T14:16:56.256Z The Bill That Could Break Biotech's Favorite Shortcut to China https://biotechmorning.com/news/fda-real-time-clinical-trials-initiative Biotech Morning en 2026-06-05T14:16:06.195Z The FDA Wants to Watch Your Clinical Trial Live. Like, Right Now. https://biotechmorning.com/news/asco-2026-china-biotech-coming-of-age Biotech Morning en 2026-06-04T14:17:28.282Z The Conference Where China Stopped Following and Started Leading https://biotechmorning.com/news/regeneron-doubles-cytomx-probody-bet Biotech Morning en 2026-06-04T14:16:57.147Z Regeneron Just Doubled a $2B Bet Most of Biotech Had Written Off https://biotechmorning.com/news/alnylam-inceptive-ai-rnai-deal Biotech Morning en 2026-06-04T14:16:01.080Z The RNAi King Just Admitted It Needs an AI Co-Pilot https://biotechmorning.com/news/autoimmune-car-t-durability-cabaletta-bio Biotech Morning en 2026-06-04T14:15:06.539Z The Autoimmune CAR-T Race Has a New Mantra: Make It Last https://biotechmorning.com/news/innovent-cldn18-2-adc-phase-3-win-takeda Biotech Morning en 2026-06-04T14:14:13.791Z Innovent's $1.2B Bet Just Got a Whole Lot More Interesting https://biotechmorning.com/news/germany-loses-pharma-investment-healthcare-reform Biotech Morning en 2026-06-04T14:13:17.645Z Germany Just Lost $2 Billion in Pharma Investment. It Asked For It.